Acumen Pharmaceuticals
ABOS
ABOS
71 hedge funds and large institutions have $75.2M invested in Acumen Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 22 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
41% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 22
Holders
71
Holding in Top 10
–
Calls
$70K
Puts
–
Top Buyers
| 1 | +$315K | |
| 2 | +$149K | |
| 3 | +$99.2K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$98.3K |
| 5 |
QC
Quadrature Capital
London,
United Kingdom
|
+$97.3K |
Top Sellers
| 1 | -$320K | |
| 2 | -$295K | |
| 3 | -$129K | |
| 4 |
Two Sigma Investments
New York
|
-$112K |
| 5 |
Goldman Sachs
New York
|
-$58.1K |
